Patients
Reverba podcast featuring CEO Cheryl Lubbert
Sponsored

Patient engagement throughout the product lifecycle

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list.

News

Press Releases

Views & Analysis

Patients
Reverba podcast featuring CEO Cheryl Lubbert
Sponsored

Patient engagement throughout the product lifecycle

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list.

Newsletters and Deep Dive
digital magazine

Deep Dive

Patients
Intellectual property: Striking the balance

Intellectual property: Striking the balance

For many spin-outs and start-ups in the pharmaceutical space, a key step in getting their science into patients is teaming up with a larger pharmaceutical company.

Webinars

Podcasts

Patients
Reverba podcast featuring CEO Cheryl Lubbert
Sponsored

Patient engagement throughout the product lifecycle

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list.

Video

R&D
Health Innovators Cytokinetics

Health Innovators – Fady Malik and Steve Heitner

In this instalment of Health Innovators, EiC Jonah Comstock sits down virtually with Fady Malik, EVP of research and development at Cytokinetics and Steve Heitner, the company’s VP of clinical rese

Digital
Reuters Pharma USA Maria Whitman

Reuters Pharma USA – Maria Whitman

At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy

White Papers

Event

Patients
Reuters Pharma Barcelona April 2023

Reuters Pharma Barcelona 2023

The Reuters Pharma 2023 event is live in Barcelona and pharmaphorum is on site to provide readers with rolling coverage of the speakers and concepts as unfolds over the next few days.

Debates & Insight

Partner Content